Study tests unilateral versus bilateral lumbar fusion

Study tests unilateral versus bilateral lumbar fusion

(HealthDay) -- For patients with degenerative lumbar diseases, the unilateral pedicle screw (PS) instrumented transforaminal lumbar interbody fusion (TLIF) procedure results in shorter operative time, less blood loss, and reduced implant costs compared with a bilateral PS instrumented TLIF procedure, according to research published in the March issue of The Spine Journal.

Huaming Xue, M.D., of the Shanghai Yangpu District Central Hospital, and colleagues conducted a prospective, randomized trial involving 80 patients with degenerative lumbar diseases who underwent the TLIF procedure using either unilateral or bilateral PS .

After an average follow-up time of 25.3 months, no significant between-group treatment differences were observed for hospital time for double-level fusion cases, measures of postoperative pain and function, total fusion rate, screw failure, or general . The researchers further note that patients who underwent a unilateral PS procedure had a significantly shorter operative time, less , and reduced implant costs compared with those who underwent the bilateral PS procedure.

"Unilateral PS instrumented TLIF is a viable treatment option generating better results, especially in terms of operative time, blood loss, and hospital time for single-level disease and implant costs. No decrease in the fusion rate or increase in the complication rate was observed," the authors conclude.

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Surgical treatment within six months of lumbar disc herniation

Oct 25, 2011

A new study in the Journal of Bone and Joint Surgery (JBJS) found that patients with herniated lumbar disc symptoms were significantly worse if the patients had symptoms for more than six months prior to treatment, compared to t ...

Recommended for you

Doctor behind 'free radical' aging theory dies

21 hours ago

Dr. Denham Harman, a renowned scientist who developed the most widely accepted theory on aging that's now used to study cancer, Alzheimer's disease and other illnesses, has died in Nebraska at age 98.

Mexican boy who had massive tumor recovering

Nov 25, 2014

An 11-year-old Mexican boy who had pieces of a massive tumor removed and who drew international attention after U.S. officials helped him get treatment in the southwestern U.S. state of New Mexico is still recovering after ...

New medical device to make the mines safer

Nov 21, 2014

Dehydration can be a serious health issue for Australia's mining industry, but a new product to be developed with input from Flinders University's Medical Device Partnering Program (MDPP) is set to more effectively ...

US family gets $6.75 million in Botox case

Nov 20, 2014

A New York couple who said Botox treatment of their son's cerebral palsy left him with life-threatening complications and sued its manufacturer won a $6.75 million verdict from a federal jury on Thursday.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.